FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts … Read more

Nine of the largest pharma companies ink deals with Trump to lower drug prices

Nine of the largest pharma companies ink deals with Trump to lower drug prices

U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White House December 19, 2025 in Washington, DC. Trump delivered remarks on lowering prescription drug prices during the event. Alex Wong | Getty Images Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump on Friday to … Read more

Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound 

Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound 

The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty Images Eli Lilly on Thursday said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking the company’s … Read more

Eli Lilly’s next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial  

Eli Lilly’s next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial  

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Thursday said its next-generation obesity drug delivered what appears to be the highest weight loss yet in a late-stage trial while reducing knee arthritis pain, clearing the first of several upcoming … Read more

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the … Read more

Could markets be facing an ‘everything bubble’? Investors are divided

Could markets be facing an ‘everything bubble’? Investors are divided

Global stocks have fluctuated wildly over the past week, as concerns about AI valuations hang over equity markets. Some respite from a four-day sell-off followed Nvidia ‘s earnings release on Wednesday, but its own gains were quickly reversed during Thursday’s trading session as New York-listed stocks lost further ground . Friday saw U.S. stocks rebound … Read more

Eli Lilly hits $1 trillion market value, a first for a health-care company

Eli Lilly hits  trillion market value, a first for a health-care company

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly reached a $1 trillion market capitalization on Friday, the first health-care company in the world to join the exclusive club dominated by tech firms.  Eli Lilly briefly hit … Read more

Week in review: Stocks swing wildly, Disney disappoints, and we make 6 trades

Week in review: Stocks swing wildly, Disney disappoints, and we make 6 trades

It was a volatile week for the stock market, with the Dow Jones Industrial Average hitting an all-time high before pulling back. Wall Street pulled money away from Big Tech and into more defensive sectors, such as health care and financials. The end of the longest-ever U.S. government shutdown and expectations for interest rate cuts … Read more

Eli Lilly stock tops $1,000 for the first time. Cramer says the next milestone is within reach

Eli Lilly stock tops ,000 for the first time. Cramer says the next milestone is within reach

CNBC’s Jim Cramer said Wednesday that Eli Lilly will soon be the first pharmaceutical company to reach a $1 trillion stock market value. Shortly after the open, shares topped $1,000 each for the first time. At session highs, the stock exceeded a $950 billion market cap. Shares would have to hit nearly $1,058 to reach … Read more